Nuala Moran

New research shows Europe needs harmonised rules and a different approach to funding to get the most from its investment in biobanks.

As the ingredients for the EU 2020 strategy are assembled, Commissioner Maire Geoghegan Quinn asks the public: What do you want in the recipe?

Innovation may rest on R&D, but it takes place in a far bigger and more diverse context, says the UK’s new science minister, David Willetts.

The technology is coming on apace, but Europe’s health services are not set up to get personalised healthcare to the patients.

Research funding is up and ideas are still flowing, but the financial crisis is making it harder to commercialise technology, say top US universities.

Personalised healthcare is a complex concept. It will be best to chew on a mouthful at a time, while keeping an eye on the bigger picture.

Tailoring the treatment to patients is a grand idea. But there are many obstacles. Science|Business organised a roundtable to debate what could be done.

Producing pluripotent stem cells from skin is valuable, but they can’t replace stem cells from embryos, say US scientists.

The old established centres are being challenged by the emergence of new poles of world science and innovation. But could this benefit Europe, the US and Japan?

The new Health and Consumer Care Commissioner John Dalli is right to put patients first, but that means tending to pharma too, writes Nuala Moran.